EQT three-lens brief
Evidence-based stock research on EQT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.92% yesterday. · Trading at 1% of its 52-week range — deep in the lower band.
- Moved -2.92% yesterday.
- Trading at 1% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- RSI at 30 — technically oversold.
- Underperforming SPY by 12.1pp over 30 days.
EQT closed at $48.69 (-2.92%) as of 2026-07-10. Market cap: $30.45B. P/E (trailing) 9.2. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 9.2 — trading at a value multiple.; analyst mean target $68.80 — 41% above current (25 analysts).. Concerns: moved -2.92% yesterday.; trading at 1% of its 52-week range — deep in the lower band.. Last quarter: Revenue $3.38B, net income $1.49B, free cash flow $2.50B. Watching for: 2026-07-21 earnings release (10 days out).
Why three lenses on EQT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine EQTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/EQT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath EQT brief"></iframe>